Cargando…

Low‐Dose, Contrast‐Enhanced Mammography Compared to Contrast‐Enhanced Breast MRI: A Feasibility Study

Contrast‐enhanced MRI (CE‐MRI) is the most sensitive technique for breast cancer detection. Contrast‐enhanced mammography (CEM) is emerging as a possible alternative to CE‐MRI. PURPOSE: To evaluate the diagnostic performance of a low radiation dose contrast‐enhanced mammography (L‐CEM) in women with...

Descripción completa

Detalles Bibliográficos
Autores principales: Clauser, Paola, Baltzer, Pascal A.T., Kapetas, Panagiotis, Hoernig, Mathias, Weber, Michael, Leone, Federica, Bernathova, Maria, Helbich, Thomas H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496227/
https://www.ncbi.nlm.nih.gov/pubmed/32061002
http://dx.doi.org/10.1002/jmri.27079
_version_ 1783583050546806784
author Clauser, Paola
Baltzer, Pascal A.T.
Kapetas, Panagiotis
Hoernig, Mathias
Weber, Michael
Leone, Federica
Bernathova, Maria
Helbich, Thomas H.
author_facet Clauser, Paola
Baltzer, Pascal A.T.
Kapetas, Panagiotis
Hoernig, Mathias
Weber, Michael
Leone, Federica
Bernathova, Maria
Helbich, Thomas H.
author_sort Clauser, Paola
collection PubMed
description Contrast‐enhanced MRI (CE‐MRI) is the most sensitive technique for breast cancer detection. Contrast‐enhanced mammography (CEM) is emerging as a possible alternative to CE‐MRI. PURPOSE: To evaluate the diagnostic performance of a low radiation dose contrast‐enhanced mammography (L‐CEM) in women with suspicious findings on conventional imaging compared to CE‐MRI of the breast. STUDY TYPE: Prospective, single center. POPULATION: Women with suspicious findings on mammography, tomosynthesis, or ultrasound, and no contraindications for L‐CEM or CE‐MRI. Eighty women were included. FIELD STRENGTH/SEQUENCE: 1.5 and 3T CE‐MRI, standard protocol for breast, with dedicated coils, according to international guidelines. L‐CEM was performed using a dedicated prototype. ASSESSMENT: Three, off‐site, blinded readers evaluated the images according to the BI‐RADS lexicon in a randomized order, each in two separate reading sessions. Histology served as a gold standard. STATISTICAL TEST: Lesion detection rate, sensitivity, specificity, and negative and positive predictive values (NPV, PPV) were calculated and compared with multivariate statistics. RESULTS: Included were 80 women (mean age, 54.3 years ±11.2 standard deviation) with 93 lesions (32 benign, 61 malignant). The detection rate was significantly higher with CE‐MRI (92.5–94.6%; L‐CEM 79.6–91.4%, P = 0.014). Sensitivity (L‐CEM 65.6–90.2%; CE‐MRI 83.6–93.4%, P = 0.086) and NPV (L‐CEM 59.6–71.4%; CE‐MRI 63.0–76.5%, P = 0.780) did not differ between the modalities. Specificity (L‐CEM 46.9–96.9%; CE‐MRI 37.5–53.1%, P = 0.001) and PPV (L‐CEM 76.4–97.6%; CE‐MRI 73.3–77.3%, P = 0.007) were significantly higher with L‐CEM. Variations between readers were significant for sensitivity and NPV. The accuracy of L‐CEM was as good as CE‐MRI (75.3–76.3% vs. 72.0–75.3%, P = 0.514). DATA CONCLUSION: L‐CEM showed a high sensitivity and accuracy in women with suspicious findings on conventional imaging. Compared to CE‐MRI, L‐CEM has the potential to increase specificity and PPV. L‐CEM might help to reduce false‐positive biopsies while obtaining sensitivity comparable to that of CE‐MRI LEVEL OF EVIDENCE: 1 TECHNICAL EFFICACY STAGE: 2 J. Magn. Reson. Imaging 2020;52:589–595.
format Online
Article
Text
id pubmed-7496227
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-74962272020-09-25 Low‐Dose, Contrast‐Enhanced Mammography Compared to Contrast‐Enhanced Breast MRI: A Feasibility Study Clauser, Paola Baltzer, Pascal A.T. Kapetas, Panagiotis Hoernig, Mathias Weber, Michael Leone, Federica Bernathova, Maria Helbich, Thomas H. J Magn Reson Imaging Original Research Contrast‐enhanced MRI (CE‐MRI) is the most sensitive technique for breast cancer detection. Contrast‐enhanced mammography (CEM) is emerging as a possible alternative to CE‐MRI. PURPOSE: To evaluate the diagnostic performance of a low radiation dose contrast‐enhanced mammography (L‐CEM) in women with suspicious findings on conventional imaging compared to CE‐MRI of the breast. STUDY TYPE: Prospective, single center. POPULATION: Women with suspicious findings on mammography, tomosynthesis, or ultrasound, and no contraindications for L‐CEM or CE‐MRI. Eighty women were included. FIELD STRENGTH/SEQUENCE: 1.5 and 3T CE‐MRI, standard protocol for breast, with dedicated coils, according to international guidelines. L‐CEM was performed using a dedicated prototype. ASSESSMENT: Three, off‐site, blinded readers evaluated the images according to the BI‐RADS lexicon in a randomized order, each in two separate reading sessions. Histology served as a gold standard. STATISTICAL TEST: Lesion detection rate, sensitivity, specificity, and negative and positive predictive values (NPV, PPV) were calculated and compared with multivariate statistics. RESULTS: Included were 80 women (mean age, 54.3 years ±11.2 standard deviation) with 93 lesions (32 benign, 61 malignant). The detection rate was significantly higher with CE‐MRI (92.5–94.6%; L‐CEM 79.6–91.4%, P = 0.014). Sensitivity (L‐CEM 65.6–90.2%; CE‐MRI 83.6–93.4%, P = 0.086) and NPV (L‐CEM 59.6–71.4%; CE‐MRI 63.0–76.5%, P = 0.780) did not differ between the modalities. Specificity (L‐CEM 46.9–96.9%; CE‐MRI 37.5–53.1%, P = 0.001) and PPV (L‐CEM 76.4–97.6%; CE‐MRI 73.3–77.3%, P = 0.007) were significantly higher with L‐CEM. Variations between readers were significant for sensitivity and NPV. The accuracy of L‐CEM was as good as CE‐MRI (75.3–76.3% vs. 72.0–75.3%, P = 0.514). DATA CONCLUSION: L‐CEM showed a high sensitivity and accuracy in women with suspicious findings on conventional imaging. Compared to CE‐MRI, L‐CEM has the potential to increase specificity and PPV. L‐CEM might help to reduce false‐positive biopsies while obtaining sensitivity comparable to that of CE‐MRI LEVEL OF EVIDENCE: 1 TECHNICAL EFFICACY STAGE: 2 J. Magn. Reson. Imaging 2020;52:589–595. John Wiley & Sons, Inc. 2020-02-14 2020-08 /pmc/articles/PMC7496227/ /pubmed/32061002 http://dx.doi.org/10.1002/jmri.27079 Text en © 2020 The Authors. Journal of Magnetic Resonance Imaging published by Wiley Periodicals, Inc. on behalf of International Society for Magnetic Resonance in Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Clauser, Paola
Baltzer, Pascal A.T.
Kapetas, Panagiotis
Hoernig, Mathias
Weber, Michael
Leone, Federica
Bernathova, Maria
Helbich, Thomas H.
Low‐Dose, Contrast‐Enhanced Mammography Compared to Contrast‐Enhanced Breast MRI: A Feasibility Study
title Low‐Dose, Contrast‐Enhanced Mammography Compared to Contrast‐Enhanced Breast MRI: A Feasibility Study
title_full Low‐Dose, Contrast‐Enhanced Mammography Compared to Contrast‐Enhanced Breast MRI: A Feasibility Study
title_fullStr Low‐Dose, Contrast‐Enhanced Mammography Compared to Contrast‐Enhanced Breast MRI: A Feasibility Study
title_full_unstemmed Low‐Dose, Contrast‐Enhanced Mammography Compared to Contrast‐Enhanced Breast MRI: A Feasibility Study
title_short Low‐Dose, Contrast‐Enhanced Mammography Compared to Contrast‐Enhanced Breast MRI: A Feasibility Study
title_sort low‐dose, contrast‐enhanced mammography compared to contrast‐enhanced breast mri: a feasibility study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496227/
https://www.ncbi.nlm.nih.gov/pubmed/32061002
http://dx.doi.org/10.1002/jmri.27079
work_keys_str_mv AT clauserpaola lowdosecontrastenhancedmammographycomparedtocontrastenhancedbreastmriafeasibilitystudy
AT baltzerpascalat lowdosecontrastenhancedmammographycomparedtocontrastenhancedbreastmriafeasibilitystudy
AT kapetaspanagiotis lowdosecontrastenhancedmammographycomparedtocontrastenhancedbreastmriafeasibilitystudy
AT hoernigmathias lowdosecontrastenhancedmammographycomparedtocontrastenhancedbreastmriafeasibilitystudy
AT webermichael lowdosecontrastenhancedmammographycomparedtocontrastenhancedbreastmriafeasibilitystudy
AT leonefederica lowdosecontrastenhancedmammographycomparedtocontrastenhancedbreastmriafeasibilitystudy
AT bernathovamaria lowdosecontrastenhancedmammographycomparedtocontrastenhancedbreastmriafeasibilitystudy
AT helbichthomash lowdosecontrastenhancedmammographycomparedtocontrastenhancedbreastmriafeasibilitystudy